Sonic Healthcare (ASX: SHL) — Stock Profile

About Sonic Healthcare (ASX: SHL)

Sonic Healthcare Limited provides medical diagnostic services alongside administrative services and facilities to medical practitioners across Australia, the United States, Germany, and a number of other international markets. The company operates primarily through laboratory medicine and pathology testing, covering disciplines such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, and toxicology, as well as a radiology division offering imaging services including MRI, CT, ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry.

Its primary care segment extends the business into general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, community-based healthcare services, and clinical trials services, reflecting a broad and integrated approach to healthcare delivery. The combination of diagnostic depth and primary care reach positions Sonic Healthcare as a diversified operator across multiple points of the patient care continuum. Incorporated in 1934, the company is headquartered in Sydney, Australia.

MFAM Research

  • [BUY] Why Sonic Healthcare Stock (ASX SHL) Is A Stock To Buy
    May 3, 2018
    Sonic Healthcare Limited (ASX SHL) is Australasia and Europe’s largest and the world’s third-largest medical laboratory provider. During the last financial year, Sonic Healthcare stock has been rewarded a government program and successfully acquired several professional laboratories, which has significantly driven revenue and increased the company’s share price. Compared to the previous year, Sonic Healthcare […]
Our Exclusive Top 5 Stock Picks

Five high conviction stocks that didn't make the public list. Backed by institutional research with significant upside potential. Subscribe for free access.

Invalid email address
By subscribing, you consent to receive communications from us. You can unsubscribe at any time.

Latest Announcements

  • Sonic Healthcare (ASX: SHL) – Sonic Healthcare FY2026 Financial Review
    August 20, 2026
    I can see the announcement text provided is incomplete—it only contains the formal cover letter and disclaimer section. The actual financial results, revenue figures, earnings, operational metrics, and other key data that would be in the full announcement are missing. The letter mentions “The slides for the presentation are enclosed” but those weren’t included in […]
  • Sonic Healthcare (ASX: SHL) – Sonic Healthcare FY2026 Full Year Results
    August 20, 2026
    Sonic Healthcare delivered full-year results to June 2026 that met guidance and demonstrated solid operational execution across its sprawling international platform. Revenue grew 13% to $10.87 billion, underpinned by organic growth of 5%, while underlying EBITDA increased 11% to $1.93 billion and underlying earnings per share climbed 14% to 125.6 cents. The result reflects the […]
  • Sonic Healthcare (ASX: SHL) – SHL Files FY2026 Preliminary Final Results
    August 20, 2026
    Sonic Healthcare delivered a strong finish to fiscal 2026, with net profit climbing 18.4% to A$608.3 million against the backdrop of 12.7% revenue growth to A$10.9 billion. The outperformance of profit growth relative to revenue growth points to meaningful operational leverage, as the pathology and imaging services provider demonstrably improved its cost structure and operational […]

Financial Summary

Price History

Same Industry — HealthcareSame Sub-Industry — Diagnostics & Research
Share This